Nirmala C. Kampan

Kuala Lumpur, Malaysia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications

Targeting Monocytes and Their Derivatives in Ovarian Cancer: Opportunities for Innovation in Prognosis and Therapy.

Targeting Monocytes and Their Derivatives in Ovarian Cancer: Opportunities for Innovation in Prognosis and Therapy.

Journal: Cancers
Published: November 06, 2025

Interleukin-6 Is a Crucial Factor in Shaping the Inflammatory Tumor Microenvironment in Ovarian Cancer and Determining Its Hot or Cold Nature with Diagnostic and Prognostic Utilities.

Interleukin-6 Is a Crucial Factor in Shaping the Inflammatory Tumor Microenvironment in Ovarian Cancer and Determining Its Hot or Cold Nature with Diagnostic and Prognostic Utilities.

Journal: Cancers
Published: March 17, 2025

Insulin-like Growth Factor 1 (IGF1) and Its Isoforms: Insights into the Mechanisms of Endometrial Cancer.

Insulin-like Growth Factor 1 (IGF1) and Its Isoforms: Insights into the Mechanisms of Endometrial Cancer.

Journal: Cancers
Published: December 04, 2024

Management paradigm for ovarian neuroendocrine carcinoma: a systematic review.

Management paradigm for ovarian neuroendocrine carcinoma: a systematic review.

Journal: Journal of ovarian research
Published: November 26, 2024

Interleukin-6 Modulation in Ovarian Cancer Necessitates a Targeted Strategy: From the Approved to Emerging Therapies.

Interleukin-6 Modulation in Ovarian Cancer Necessitates a Targeted Strategy: From the Approved to Emerging Therapies.

Journal: Cancers
Published: October 16, 2024

Gene expression and soluble protein level of PD-1 and its ligands (PD-L1 and PD-L2) in endometrial cancer.

Gene expression and soluble protein level of PD-1 and its ligands (PD-L1 and PD-L2) in endometrial cancer.

Journal: PloS one
Published: June 26, 2024

Unlocking ovarian cancer heterogeneity: advancing immunotherapy through single-cell transcriptomics.

Unlocking ovarian cancer heterogeneity: advancing immunotherapy through single-cell transcriptomics.

Journal: Frontiers in oncology
Published: February 20, 2024

Therapeutic effects of surgical debulking of metastatic lymph nodes in cervical cancer IIICr: a trial protocol for a phase III, multicenter, randomized controlled study (KGOG1047/DEBULK trial).

Therapeutic effects of surgical debulking of metastatic lymph nodes in cervical cancer IIICr: a trial protocol for a phase III, multicenter, randomized controlled study (KGOG1047/DEBULK trial).

Journal: Journal of gynecologic oncology
Published: November 01, 2023

Recent Advances in Surface Plasmon Resonance (SPR) Technology for Detecting Ovarian Cancer Biomarkers.

Recent Advances in Surface Plasmon Resonance (SPR) Technology for Detecting Ovarian Cancer Biomarkers.

Journal: Cancers
Published: October 16, 2023

Expression of PD-1 and PD-L1 in Endometrial Cancer: Molecular and Clinical Significance.

Expression of PD-1 and PD-L1 in Endometrial Cancer: Molecular and Clinical Significance.

Journal: International journal of molecular sciences
Published: September 11, 2023

Efficacy and Safety of PD-1/PD-L1 Inhibitor as Single-Agent Immunotherapy in Endometrial Cancer: A Systematic Review and Meta-Analysis.

Efficacy and Safety of PD-1/PD-L1 Inhibitor as Single-Agent Immunotherapy in Endometrial Cancer: A Systematic Review and Meta-Analysis.

Journal: Cancers
Published: June 28, 2023

Combining TNFR2-Expressing Tregs and IL-6 as Superior Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Masses.

Combining TNFR2-Expressing Tregs and IL-6 as Superior Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Masses.

Journal: Cancers
Published: December 10, 2022
Showing 1-12 of 39

Last Updated: 09/26/2026